← Back to Company DatabaseVisit Website
Cleancard
At-home rapid cancer detection tests from urine samples.
Pre-seed / SeedLondon, UKFounded 2021
About
Cleancard combines synthetic biology, machine learning, and computer vision to make cancer detection as easy as a pregnancy test. Founded by two Rhodes Scholars at Oxford, the company is developing fully at-home 30-minute tests that detect multiple cancer biomarkers from a single urine sample, starting with prostate, bladder, and ovarian cancers.
Total Funding
$5MKey Product
Cleancard at-home rapid cancer screening testGeography
EuropeKey Investors
Y CombinatorCreative Destruction LabUrban Innovation Fund
Focus Areas
Early Detection / ScreeningDiagnostics
Technology
AI / Machine LearningOther
Cancer Types
ProstateOther
Last updated: Feb 4, 2026